Evidence Review-Chronic Disease Prevention and Management Assessment Answer

Introduction

Type 2 Diabetes (T2D) is a chronic metabolic disorder with insulin resistance and high blood sugar levels. CVD refers to a class of diseases related to the heart and blood vessels, which often involve risk factors such as hypertension and diabetes. This essay explores the close relationship between T2D and CVD, with a special focus on orthopaedic nursing. Moreover, the essay explores the worldwide and Australian epidemiological stage, pointing to the ever-increasing burden of T2D and CVD. Furthermore, two healthcare interventions for co-morbid chronic health conditions are considered to promote holistic medical care and enhance overall levels of health.

Prevalence, interdependence between T2D and CVD

CVD and T2D share several common risk factors that are interrelated. Among them, obesity, inactivity, poor nutrition and smoking lead to both diseases. Atherosclerosis initiation is an important step in CVD, and it defines T2D (Giugliano et al., 2019). T2D can accelerate the underlying process of many cardiovascular diseases: oxidative stress and inflammation caused by T2D lead to endothelial dysfunction and arterial stiffening. The changes create an environment in which CVDs, including coronary artery disease and stroke (Wang et al., 2022), can arise and progress. T2D and CVD affect musculoskeletal health, influencing orthopaedic results and treatment strategies.T2D and CVD can contribute to musculoskeletal issues, such as osteoarthritis and osteoporosis. Diabetes, with its associated metabolic changes, may affect joint health, potentially leading to conditions like Charcot arthropathy. CVD, especially peripheral arterial disease, can compromise blood flow to the extremities, impacting bone and tissue health (Aston, 2019). Diabetes-related complications, like delayed wound healing and increased infection risk, may necessitate close monitoring postoperatively. Cardiovascular concerns, such as coronary artery disease, may influence the choice of anaesthesia and overall surgical risk assessment (Aston, 2019).

Between 2000 and 2021, over 1.3 million individuals in Australia received a new diagnosis of T2D, contributing to a substantial health burden (AIHW, 2022). In 2023, T2D accounted for approximately 124,000 years of healthy life lost, representing 2.2% of Australia's total disease burden and ranking as the 11th leading specific cause. Notably, in the 2020–21 period, diabetes-related expenses in the Australian health system reached an estimated $3.4 billion, constituting 2.3% of total disease expenditure, with T2D contributing significantly at 68% (AIHW 2023a). In 2021, coronary heart disease (CHD) emerged as the primary cause of death in Australia, claiming 17,300 lives, with 38% (6,500) attributed to heart attacks. Acute coronary events, such as heart attacks or unstable angina, affected 56,700 people aged 25 and over in 2020, translating to an alarming 155 events daily. (AIHW, 2022; 2023b). The association between diabetes and elevated blood glucose levels and an approximately twofold increase in the risk of CVD is well-documented (Cosentino et al., 2018). Individuals with T2D face a mortality rate nearly doubling when coexisting with CVD, resulting in an estimated 12-year reduction in life expectancy. Furthermore, those with T2D typically experience atherosclerotic CVD earlier and with greater severity compared to their counterparts without the condition (Marson et al., 2021; Cosentino et al., 2018). In 2017, the global prevalence of T2D reached approximately 462 million individuals, constituting 6.28% of the world's population. The overall prevalence rate was 6059 cases per 100,000 individuals. The burden of diabetes mellitus is on the rise globally, with developed regions like Western Europe experiencing a notably faster increase. (Khan et al., 2020). Globally, CVD is becoming more prevalent; from 12.1 million in 1990 to 20.5 million in 2021, deaths linked to CVD rose. The World Heart Federation (WHF) reports that in 2021, CVD was the primary cause of mortality globally (WHO, 2022; WHF, 2023).

Healthcare interventions

According to Vasiloglou et al. (2019), nutritional counselling and weight control awareness on controlling body mass and decreasing dangerous meals consumption at the same time as also regulating metabolism and different metabolic factors that can have an effect on orthopaedics. Research has proven time and time again that obesity, diabetes, and cardiovascular disorders are associated (Piché et al., 2020; Powell-Wiley et al., 2021). Interventions for weight reduction can assist human beings with T2D to gain better glycemic control and lower their cardiovascular threat elements (Mirabelli et al., 2019). Nutritional control is an extra strategy that has been verified in several trials to lower cardiovascular-cerebrovascular occasions in diabetic patients (Pandey et al., 2020). Several institutions have set up recommendations, which include the National Health and Medical Research Council and Dietary Guideline Index, which advocate that weight control techniques and individualised dietary interventions are important components of diabetes therapy (Ward et al., 2019). RNs imparting weight control interventions need to additionally observe the suggestions for assessing absolute CVD (RACGP, 2023). To perform hazard evaluations, there is a need to offer individualised advice and warnings on how to modify life in terms of food regimen, workout stoppage, smoking and strain stages. Moreover, orthopaedic care needs to focus on maintaining the fitness of the musculoskeletal device, which is specifically legitimate. When orthopaedic problems have developed, being overweight can worsen the pain and restrict movement (Powell-Wiley et al., 2021). For patients with two diseases, the risk of body damage from carbohydrate overload must often be balanced against the side effects of insulin treatment for T2D and CVD. Nurses who work in orthopaedic nursing serve to carefully do a full nutritional assessment for these patients as well. They collaborate closely with dietitians to develop personalised meal plans that address the nutritional needs associated with T2D/CVD and orthopaedic problems (Aston, 2019). Such cooperation means that the dietary therapies would help in glycemic control and cardiovascular risk and improve the musculoskeletal health of orthopaedic patients. In orthopaedics, RNs educate patients about portion control, carb counting, and choosing a diet specific to their musculoskeletal needs. Trained registered nurses who understand that weight can influence orthopaedic diseases evaluate the weight statuses of patients and, in appropriate cases, set reasonable targets for reducing their weights (Razaz et al., 2019). Further, nurses working in orthopaedics encourage and help with lifestyle changes. They emphasise the importance of behaviours that contribute to a strong musculoskeletal system, such as reasonable physical activity, smoking cessation, and stress management (Razaz et al., 2019). Working with orthopaedic specialists, physicians create safe and effective exercise regimens suitable to each patient's orthopaedic health status.

In caring for patients with T2D and CVD, RNs must assume an active role in medication management and adherence support. This covers teaching patients about their medications, appropriate dosing, possible side effects and overcoming barriers to compliance (Hills et al., 2022). During the administration of prescribed drugs, RNs in the field of orthopaedics are also considerate about how such drug use can affect later surgical interventions or post-operative care. For example, drugs antiplatelet and anticoagulant agents given to provide fundamental cardiac protection influence the use of methods for pain management during inflammation therapy. At the same time, a patient undergoes orthopaedic intervention (Lichota et al., 2020). This puts a noteworthy trial in being able to achieve compliance with drug intake. The health issues involved almost always lead to complications that yield discomfort and impairment within mobility, factors which together rob a patient of his or her desire or ability to commit medicinal schedules properly. Identifying and overcoming barriers to adherence is a major responsibility of orthopaedic RNs (Shockney et al., 2021). Ways of overcoming these obstacles include drawing up personalised plans, attending to misunderstandings or concerns, and establishing a communication environment. As for the safe management of medication, particularly concerning T2D and CVD, RNs on orthopaedic wards must make clear the importance of taking medications that affect diabetes and cardiovascular problems, as was observed in clinical trials such as the Diabetes Control & Complications Trial (DCCT) (Lachin & Nathan, 2021). T2D is mainly managed with a combination of oral antidiabetic drugs and insulin; these drugs maintain the blood glucose levels so that observed adhesiveness means stable sugar amounts thus reducing risks of hyperglycemia, which itself causes various cardiovascular problems (Ganesan & Sultan, 2019). T2D patients usually also take antihypertensive medications, which may include ACE inhibitors or beta-blockers. Cardiovascular risks are significantly exacerbated by dyslipidemia, a prevalent illness among individuals with T2D and abnormal lipid levels (Petrie et al., 2019). In order to minimise the risk of cardiac problems such as atherosclerosis and other inflammatory events in blood vessels, it is imperative that these drugs be properly monitored. It has been demonstrated that, in orthopaedic wards in particular, blood sugar control effectively lowers the risk of infection while promoting appropriate wound healing techniques during rehabilitation procedures, promoting better overall outcomes leading to patients' recovery without requiring additional complexity during their therapy sessions through careful management of both heart-related and diabetic medications under the supervision of registered nurses on staff members' guidelines (Burgess et al., 2021).

Conclusion

A multimodal method is essential for the care of orthopaedic patients without T2 and CVD. The commonplace modifiable danger factors that make a contribution to their improvement are weight problems, physical inaction, and horrific diets. The biochemical linkage between atherosclerosis, which is related to CVD, and insulin resistance, which is, without delay, related to T2D, is complex, as we will see. Effective treatment techniques require tailor-made remedies, together with medicine steerage and evidence-based weight management plans. Specifically, the two chronic illnesses and their related situations have had a tremendous effect on people's high-quality existence on a countrywide and worldwide scale.

References

‌‌‌Australian Institute of Health and Welfare (AIHW). (2023a). Australian Burden of Disease Study 2023, About. https://www.aihw.gov.au/reports/burden-of-disease/australian-burden-of-disease-study-2023/contents/about

‌‌Australian Institute of Health and Welfare (AIHW). (2023b). Heart, stroke and vascular disease: Australian facts, Diabetes.https://www.aihw.gov.au/reports/heart-stroke-vascular-disease/hsvd-facts/contents/risk-factors/diabetes#

‌Aston, B. C. (2019). Addressing Obesity in Orthopedics. JBJS Journal of Orthopaedics for Physician Assistants , 7 (3), e0004. https://doi.org/10.2106/jbjs.jopa.19.00004

‌Australian Commission on Safety and Quality in Health Care (ACSQHC). (2022). Medication safety standard. https://www.safetyandquality.gov.au/standards/nsqhs-standards/medication-safety-standard

‌Australian Institute of Health and Welfare (AIHW). (2022). Diabetes: Australian facts, Summary. https://www.aihw.gov.au/reports/diabetes/diabetes/contents/summary

‌Burgess, J. L., Wyant, W. A., Abdo Abujamra, B., Kirsner, R. S., & Jozic, I. (2021). Diabetic Wound-Healing Science. Medicina , 57 (10), 1072. https://doi.org/10.3390/medicina57101072

‌Cosentino, F., Ceriello, A., Baeres, F. M. M., Fioretto, P., Garber, A., Stough, W. G., George, J. T., Grant, P. J., Khunti, K., Langkilde, A. M., Plutzky, J., Rydén, L., Scheen, A., Standl, E., Tuomilehto, J., & Zannad, F. (2018). Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable. European Heart Journal , 40 (34), 2907–2919. https://doi.org/10.1093/eurheartj/ehy677

Ganesan, K. & Senan Sultan, S. (2019). Oral hypoglycemic medications. https://www.ncbi.nlm.nih.gov/books/NBK482386/

Giugliano, D., Maiorino, M. I., Bellastella, G., Chiodini, P., & Esposito, K. (2019). Glycemic control, preexisting cardiovascular disease, and risk of major cardiovascular events in patients with type 2 diabetes mellitus: systematic review with meta‐analysis of cardiovascular outcome trials and intensive glucose control trials. Journal of the American Heart Association , 8 (12), e012356.https://doi.org/10.1161/JAHA.119.012356

‌Hills, S., Terry, D., Gazula, S., & Browning, C. (2022). Practice nurses’ communication with people living with type 2 diabetes: A scoping review. Patient Education and Counseling , 105 (8). https://doi.org/10.1016/j.pec.2022.03.024

‌Khan, M. A., Hashim, M. J., King, J., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health , 10 (1), 107–111. https://doi.org/10.2991/jegh.k.191028.001

‌Lachin, J. M., & Nathan, D. M. (2021). Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on future risks of complications during the study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care , 44 (10), 2216–2224. https://doi.org/10.2337/dc20-3097

‌Lichota, A., Szewczyk, E. M., & Gwozdzinski, K. (2020). Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds. International Journal of Molecular Sciences , 21 (21), 7975. https://doi.org/10.3390/ijms21217975

‌Marson, A., Raffoul, N., Osman, R., & Deed, G. (2021). Management of patients with type 2 diabetes and cardiovascular disease in primary care. Australian Journal of General Practice , 50 (4), 238–245. https://doi.org/10.31128/ajgp-02-20-5222

Mirabelli, M., Chiefari, E., Caroleo, P., Arcidiacono, B., Corigliano, D. M., Giuliano, S., Brunetti, F. S., Tanyolaç, S., Foti, D. P., Puccio, L., & Brunetti, A. (2019). Long-term effectiveness of liraglutide for weight management and glycemic control in Type 2 Diabetes. International Journal of Environmental Research and Public Health , 17 (1), 207. https://doi.org/10.3390/ijerph17010207

‌Pandey, A., Patel, K. V., Bahnson, J. L., Gaussoin, S. A., Martin, C. K., Balasubramanyam, A., Johnson, K. C., McGuire, D. K., Bertoni, A. G., Kitzman, D., & Berry, J. D. (2020). association of intensive lifestyle intervention, fitness, and body mass index with risk of heart failure in overweight or obese adults with Type 2 Diabetes Mellitus. Circulation , 141 (16), 1295–1306. https://doi.org/10.1161/circulationaha.119.044865

‌Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2019). Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. The Canadian Journal of Cardiology , 34 (5), 575–584. https://doi.org/10.1016/j.cjca.2017.12.005

‌Piché, M.-E., Tchernof, A., & Després, J.-P. (2020). Obesity phenotypes, diabetes, and cardiovascular diseases. Circulation Research , 126 (11), 1477–1500. https://doi.org/10.1161/circresaha.120.316101

‌Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., & St-Onge, M.-P. (2021). obesity and cardiovascular disease: A scientific statement from the american heart association. Circulation , 143 (21). https://doi.org/10.1161/cir.0000000000000973

‌Razaz, J. M., Rahmani, J., Varkaneh, H. K., Thompson, J., Clark, C., & Abdulazeem, H. M. (2019). The health effects of medical nutrition therapy by dietitians in patients with diabetes: A systematic review and meta-analysis: Nutrition therapy and diabetes. Primary Care Diabetes , 13 (5), 399–408. https://doi.org/10.1016/j.pcd.2019.05.001

Shockney, L. D., Dean, M., & Allard, B. L. (2021). Chronic Disease and Complex Care Navigators: A Scoping Review. Journal of Oncology Navigation & Survivorship , 12 (7). https://www.jons-online.com/issues/2021/july-2021-vol-12-no-7/3852-chronic-disease-and-complex-care-navigators-a-scoping-review

‌The Royal Australian College of General Practitioners (RACGP). (2023). Red Book Prevention of vascular and metabolic disease Assessment of absolute cardiovascular risk https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/guidelines-for-preventive-activities-in-general-pr/prevention-of-vascular-and-metabolic-disease/assessment-of-absolute-cardiovascular-risk#:~:text=Absolute%20CVD%20risk%20assessment%20combines,frame%20(usually%20five%20years).

‌Vasiloglou, M. F., Fletcher, J., & Poulia, K.-A. (2019). Challenges and perspectives in nutritional counselling and nursing: A narrative review. Journal of Clinical Medicine , 8 (9). https://doi.org/10.3390/jcm8091489

‌Wang, M., Huang, J., Wu, T., & Qi, L. (2022). arterial stiffness, genetic risk, and Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care . https://doi.org/10.2337/dc21-1921

‌Ward, S. J., Coates, A. M., & Hill, A. M. (2019). application of an australian dietary guideline index to weighed food records. Nutrients , 11 (6), 1286. https://doi.org/10.3390/nu11061286

World Health Organization (WHO). (2022). Cardiovascular Diseases. https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1

‌World Heart Report (WHF). (2023). Confronting the world’s number one killer. https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf

You Might Also Like:-

Human Nutrition Nursing Assignment Help

Health Variations 2 - Chronic Illness And Disability Assessment Answer

NRS82005 Chronic Disease Management Assignment Sample

Looking For Complete Assignment Sample Get It On WhatsApp